Givinostat

An orally bioavailable hydroxymate inhibitor of histone deacetylase (HDAC) with potential anti-inflammatory, anti-angiogenic, and antineoplastic activities. Givinostat inhibits class I and class II HDACs, resulting in an accumulation of highly acetylated histones, followed by the induction of chromatin remodeling and an altered pattern of gene expression. At low, nonapoptotic concentrations, this agent inhibits the production of pro-inflammatory cytokines such as tumor necrosis factor- (TNF-), interleukin-1 (IL-1), IL-6 and interferon-gamma. Givinostat has also been shown to activate the intrinsic apoptotic pathway, inducing apoptosis in hepatoma cells and leukemic cells. This agent may also exhibit anti-angiogenic activity, inhibiting the production of angiogenic factors such as IL-6 and vascular endothelial cell growth factor (VEGF) by bone marrow stromal cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

Giveaway

Give

Transfer possession of something to some person or group.

GITRL RNA-transfected Autologous Dendritic Cell Vaccine

An autologous dendritic cell (DC) cancer vaccine with potential immunostimulatory activity. GITRL RNA-transfected autologous DC vaccine is prepared by transfecting DCs with…

Gitelman Syndrome

An inherited disorder caused by mutations in the SLC12A3 gene. It is characterized by deficient reabsorption of electrolytes in the distal convoluted…

GIT2 wt Allele

Human GIT2 wild-type allele is located in the vicinity of 12q24.1 and is approximately 66 kb in length. This allele, which encodes…

GIT2 Gene

This gene is involved in signal transduction and regulation of receptor signaling.